The antibody developer ArGEN-X NV has joined forces with the dermatology expert LEO Pharma A/S to investigate an antibody therapeutic for the treatment of inflammation-related skin diseases. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
